J&J | JNJ - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
AbbVie USD 41.64B 458M 2026-06
Abbott USD 18.38B 1.88B 2026-03
Amgen USD 25.5B 547M 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Baxter International USD 3.59B 102M 2026-06
Bayer EUR 33.46B 875M 2026-03
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Biogen USD 3.92B 918.2M 2026-06
Boston Scientific USD 6.43B 1.86B 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
CONMED USD 455.4M 162.68M 2026-06
Cooper Companies USD 1.8B 209M 2026-03
Dexcom USD 2.36B 133.9M 2026-06
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Globus Medical USD 479.35M 3.12M 2026-06
Insulet USD 744.2M 56.7M 2026-06
Integra LifeSciences USD 330.88M 15.96M 2026-06
Intuitive Surgical USD 2.58B 65.1M 2026-06
J&J USD 54.9B 2.82B 2026-06
Medtronic USD 9.5B 440M 2025-12
Merck USD 27.73B 786M 2026-06
Merit Medical Systems USD 264.93M 48.06M 2026-06
Novartis USD 31.75B 374M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Stryker USD 6.68B 369M 2026-06
Tandem Diabetes Care USD 253M 5.05M 2026-06
Teva Pharmaceutical Industries USD 15.65B 2.11B 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06
Zoetis USD 2.06B 8M 2026-06